Cogent Biosciences (COGT) Net Equity Issued and Repurchased (2017 - 2025)

Cogent Biosciences (COGT) has 6 years of Net Equity Issued and Repurchased data on file, last reported at $135.0 million in Q4 2025.

• On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $135.0 million in Q4 2025; TTM through Dec 2025 was $159.3 million, a 1.55% decrease from a year earlier, with the FY2025 full-year figure at $159.3 million, changed N/A from the prior year.
• Net Equity Issued and Repurchased for Q4 2025 stood at $135.0 million, up from $24.3 million in the prior quarter.
• Over the last five years, Net Equity Issued and Repurchased for COGT reached as high as $161.8 million in Q2 2023 and fell as low as $24.3 million in Q1 2025.